|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin SH, Raju GS, Huff C, Ye Y, Gu J, Chen
JS, Hildebrandt MAT, Liang H, Menter DG, Morris J, et al: The
somatic mutation landscape of premalignant colorectal adenoma. Gut.
67:1299–1305. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marschner N, Zacharias S, Lordick F,
Hegewisch-Becker S, Martens U, Welt A, Hagen V, Gleiber W, Bohnet
S, Kruggel L, et al: Association of disease progression with
health-related quality of life among adults with breast, lung,
pancreatic, and colorectal cancer. JAMA Netw Open. 3:e2006432020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiorean EG, Nandakumar G, Fadelu T, Temin
S, Alarcon-Rozas AE, Bejarano S, Croitoru AE, Grover S, Lohar PV,
Odhiambo A, et al: Treatment of patients with late-stage colorectal
cancer: ASCO resource-stratified guideline. JCO Glob Oncol.
6:414–438. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Runge KW and Zakian VA: TEL2, an essential
gene required for telomere length regulation and telomere position
effect in Saccharomyces cerevisiae. Mol Cell Biol. 16:3094–3105.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saxton RA and Sabatini DM: mTOR signaling
in growth, metabolism, and disease. Cell. 169:361–371. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brown MC and Gromeier M: MNK controls
mTORC1: Substrate association through regulation of TELO2 binding
with mTORC1. Cell Rep. 18:1444–1457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takai H, Wang RC, Takai KK, Yang H and de
Lange T: Tel2 regulates the stability of PI3K-related protein
kinases. Cell. 131:1248–1259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bahrami A, Khazaei M, Hasanzadeh M,
ShahidSales S, Joudi Mashhad M, Farazestanian M, Sadeghnia HR,
Rezayi M, Maftouh M, Hassanian SM and Avan A: Therapeutic potential
of targeting PI3K/AKT pathway in treatment of colorectal cancer:
Rational and progress. J Cell Biochem. 119:2460–2469. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaizuka T, Hara T, Oshiro N, Kikkawa U,
Yonezawa K, Takehana K, Iemura S, Natsume T and Mizushima N: Tti1
and Tel2 are critical factors in mammalian target of rapamycin
complex assembly. J Biol Chem. 285:20109–20116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takai H, Xie Y, de Lange T and Pavletich
NP: Tel2 structure and function in the Hsp90-dependent maturation
of mTOR and ATR complexes. Genes Dev. 24:2019–2030. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fernandez-Saiz V, Targosz BS, Lemeer S,
Eichner R, Langer C, Bullinger L, Reiter C, Slotta-Huspenina J,
Schroeder S, Knorn AM, et al: SCFFbxo9 and CK2 direct the cellular
response to growth factor withdrawal via Tel2/Tti1 degradation and
promote survival in multiple myeloma. Nat Cell Biol. 15:72–81.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morais-Rodrigues F, Silv Erio-Machado R,
Kato RB, Rodrigues DLN, Valdez-Baez J, Fonseca V, San EJ, Gomes
LGR, Dos Santos RG, Vinicius Canário Viana M, et al: Analysis of
the microarray gene expression for breast cancer progression after
the application modified logistic regression. Gene. 726:1441682020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng SW, Chen Y, Tsai WC, Chiou HC, Wu ST,
Huang LC, Lin C, Hsieh CC, Yang YJ and Hueng DY: Overexpression of
TELO2 decreases survival in human high-grade gliomas. Oncotarget.
7:46056–46066. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gala MK, Mizukami Y, Le LP, Moriichi K,
Austin T, Yamamoto M, Lauwers GY, Bardeesy N and Chung DC: Germline
mutations in oncogene-induced senescence pathways are associated
with multiple sessile serrated adenomas. Gastroenterology.
146:520–529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang G, Murashige DS, Humphrey SJ and
James DE: A positive feedback loop between Akt and mTORC2 via SIN1
phosphorylation. Cell Rep. 12:937–943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lampada A, O'Prey J, Szabadkai G, Ryan KM,
Hochhauser D and Salomoni P: mTORC1-independent autophagy regulates
receptor tyrosine kinase phosphorylation in colorectal cancer cells
via an mTORC2-mediated mechanism. Cell Death Differ. 24:1045–1062.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Qi J, Yu J, Chen H, Zou Z, Lin X
and Guo L: Overexpression of rictor protein in colorectal cancer is
correlated with tumor progression and prognosis. Oncol Lett.
14:6198–6202. 2017.PubMed/NCBI
|
|
20
|
Creytens D: NKX2.2 immunohistochemistry in
the distinction of ewing sarcoma from cytomorphologic mimics:
Diagnostic utility and pitfalls-comment on russell-goldman et
al. Cancer Cytopathol. 127:2022019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Y, Zhang W, Guo Z, Ma F, Wu Y, Bai Y,
Gong W, Chen Y, Cheng T, Zhi F, et al: Inhibition of the
transcription factor Sp1 suppresses colon cancer stem cell growth
and induces apoptosis in vitro and in nude mouse xenografts.
Oncol Rep. 30:1782–1792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Liu J, Wang W, Xiang L, Wang J,
Liu S, Zhou H and Guo Z: High expression of hnRNPA1 promotes cell
invasion by inducing EMT in gastric cancer. Oncol Rep.
39:1693–1701. 2018.PubMed/NCBI
|
|
23
|
Park SJ, Yoon BH, Kim SK and Kim SY:
GENT2: An updated gene expression database for normal and tumor
tissues. BMC Med Genomics. 12 (Suppl 5):S1012019. View Article : Google Scholar
|
|
24
|
Carroll B: Spatial regulation of mTORC1
signalling: Beyond the Rag GTPases. Semin Cell Dev Biol.
107:103–111. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rabanal-Ruiz Y and Korolchuk VI: mTORC1
and nutrient homeostasis: The central role of the lysosome. Int J
Mol Sci. 19:8182018. View Article : Google Scholar
|
|
26
|
Li X and Gao T: mTORC2 phosphorylates
protein kinase Cζ to regulate its stability and activity. EMBO Rep.
15:191–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Knudsen JR, Fritzen AM, James DE, Jensen
TE, Kleinert M and Richter EA: Growth factor-dependent and
-independent activation of mTORC2. Trends Endocrinol Metab.
31:13–24. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Manning BD and Toker A: AKT/PKB signaling:
Navigating the network. Cell. 169:381–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jia R and Bonifacino JS: Lysosome
positioning influences mTORC2 and AKT signaling. Mol Cell.
75:26–38.e3. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao J, Zhai B, Gygi SP and Goldberg AL:
mTOR inhibition activates overall protein degradation by the
ubiquitin proteasome system as well as by autophagy. Proc Natl Acad
Sci USA. 112:15790–15797. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gkountakos A, Pilotto S, Mafficini A,
Vicentini C, Simbolo M, Milella M, Tortora G, Scarpa A, Bria E and
Corbo V: Unmasking the impact of Rictor in cancer: Novel insights
of mTORC2 complex. Carcinogenesis. 39:971–980. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang S, Qian G, Zhang QQ, Yao Y, Wang D,
Chen ZG, Wang LJ, Chen M and Sun SY: mTORC2 suppresses
GSK3-dependent snail degradation to positively regulate cancer cell
invasion and metastasis. Cancer Res. 79:3725–3736. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Serrano I, McDonald PC, Lock FE and Dedhar
S: Role of the integrin-linked kinase (ILK)/Rictor complex in
TGFβ-1-induced epithelial-mesenchymal transition (EMT). Oncogene.
32:50–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pan SJ, Zhan SK, Pan YX, Liu W, Bian LG,
Sun B and Sun QF: Tetraspanin 8-rictor-integrin α3 complex is
required for glioma cell migration. Int J Mol Sci. 16:5363–5374.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao D, Wan L, Inuzuka H, Berg AH, Tseng A,
Zhai B, Shaik S, Bennett E, Tron AE, Gasser JA, et al: Rictor forms
a complex with Cullin-1 to promote SGK1 ubiquitination and
destruction. Mol Cell. 39:797–808. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo Z, Zhou Y, Evers BM and Wang Q: Rictor
regulates FBXW7-dependent c-Myc and cyclin E degradation in
colorectal cancer cells. Biochem Biophys Res Commun. 418:426–432.
2012. View Article : Google Scholar : PubMed/NCBI
|
